Real-time three-dimensional echocardiography for detection of cardiac sarcoidosis in the early stage: a cross-sectional single-centre study

References

• Iannuzzi MC, Fontana JR. Sarcoidosis: clinical presentation, immunopathogenesis, and therapeutics. JAMA. 2011;305(4):391–399.
   PubMed Web of Science ®Google Scholar
• Martusewicz-Boros MM, Boros PW, Wiatr E, et al. Prevalence of cardiac sarcoidosis in white population: a case–control study: Proposal for a novel risk index based on commonly available tests. Medicine. 2016;95(32):e4518.
   PubMed Web of Science ®Google Scholar
• Cooper LT, Baughman KL, Feldman AM, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American heart association, the American college of cardiology, and the European society of cardiology endorsed by the heart failure society of America and the heart failure association of the European society of cardiology. Eur Heart J. 2007;28(24):3076–3093.
   PubMed Web of Science ®Google Scholar
• Uemura A, Morimoto S, Kato Y, et al. Relationship between basal thinning of the interventricular septum and atrioventricular block in patients with cardiac sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2005;22(1):63–65.
   PubMed Web of Science ®Google Scholar
• Birnie DH, Sauer WH, Bogun F, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11(7):1305–1323.
   PubMed Web of Science ®Google Scholar
• Soliman OII, van Dalen BM, Nemes A, et al. Quantification of left ventricular systolic dyssynchrony by real-time three-dimensional echocardiography. J Am Soc Echocardiogr. 2009;22(3):232–239.
   PubMed Web of Science ®Google Scholar
• Mitchell C, Rahko PS, Blauwet LA, et al. Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: Recommendations from the american society of echocardiography. J Am Soc Echocardiogr. 2019;32(1):1–64.
   PubMed Web of Science ®Google Scholar
• Kandolin R, Lehtonen J, Graner M, et al. Diagnosing isolated cardiac sarcoidosis. J Intern Med. 2011;270(5):461–468.
   PubMed Web of Science ®Google Scholar
• Isobe M, Tezuka D. Isolated cardiac sarcoidosis: clinical characteristics, diagnosis and treatment. Int J Cardiol. 2015;182:132–140.
   PubMed Web of Science ®Google Scholar
• Takaya Y, Kusano KF, Nakamura K, et al. Comparison of outcomes in patients with probable versus definite cardiac sarcoidosis. Am J Cardiol. 2015;115(9):1293–1297.
   PubMed Web of Science ®Google Scholar
• Burstow DJ, Tajik AJ, Bailey KR, et al. Two-dimensional echocardiographic findings in systemic sarcoidosis. Am J Cardiol. 1989;63(7):478–482.
   PubMed Web of Science ®Google Scholar
• Mehta D, Lubitz SA, Frankel Z, et al. Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing. Chest. 2008;133(6):1426–1435.
   PubMed Web of Science ®Google Scholar
• Freeman AM, Curran-Everett D, Weinberger HD, et al. Predictors of cardiac sarcoidosis using commonly available cardiac studies. Am J Cardiol. 2013;112(2):280–285.
   PubMed Web of Science ®Google Scholar
• Schouver ED, Moceri P, Doyen D, et al. Early detection of cardiac involvement in sarcoidosis with 2-dimensional speckle-tracking echocardiography. Int J Cardiol. 2017;227:711–716.
   PubMed Web of Science ®Google Scholar
• Chen J, Lei J, Scalzetti E, et al. Myocardial contractile patterns predict future cardiac events in sarcoidosis. Int J Cardiovasc Imaging. 2018;34(2):251–262.
   PubMed Web of Science ®Google Scholar
• Bayat F, Fahimi A, Tavana S, et al. Subclinical involvement of the heart and its associated factors in patients with sarcoidosis with normal systolic function using 2D speckle tracking. Echocardiography. 2020;37(1):41–46.
   PubMed Web of Science ®Google Scholar
• Ise T, Hasegawa T, Morita Y, et al. Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis. Heart. 2014;100(15):1165–1172.
   PubMed Web of Science ®Google Scholar
• Greulich S, Deluigi CC, Gloekler S, et al. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. JACC Cardiovasc Imaging. 2013;6(4):501–511.
   PubMed Web of Science ®Google Scholar
• Blankstein R, Kramer CM, Chandrashekhar Y. The challenges of diagnosing cardiac sarcoidosis. JACC Cardiovasc Imaging. 2017;10(12):1534–1536.
   PubMed Web of Science ®Google Scholar
• Slart RHJA, Glaudemans AWJM, Lancellotti P, Document Reading Group, et al. A joint procedural position statement on imaging in cardiac sarcoidosis: from the cardiovascular and inflammation & infection committees of the European association of nuclear medicine, the European association of cardiovascular imaging, and the American society of nuclear cardiology. J Nucl Cardiol. 2018;25(1):298–319.
   PubMed Web of Science ®Google Scholar
• Shimada T, Shimada K, Sakane T, et al. Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging. Am J Med. 2001;110(7):520–527.
   PubMed Web of Science ®Google Scholar
• Osborne MT, Hulten EA, Singh A, et al. Reduction in F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis. J Nucl Cardiol. 2014;21(1):166–174.
   PubMed Web of Science ®Google Scholar
• Sperry BW, Tamarappoo BK, Oldan JD, et al. Prognostic impact of extent, severity, and heterogeneity of abnormalities on 18F-FDG PET Scans for Suspected Cardiac Sarcoidosis. JACC Cardiovasc Imaging. 2018;11(2 Pt 2):336–345.
   PubMed Web of Science ®Google Scholar
• Blankstein R, Osborne M, Naya M, et al. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol. 2014;63(4):329–336.
   PubMed Web of Science ®Google Scholar
• Ishimaru S, Tsujino I, Takei T, et al. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images in- dicates cardiac involvement of sarcoidosis. Eur Heart J. 2005;26(15):1538–1543.
   PubMed Web of Science ®Google Scholar
• Youssef G, Leung E, Mylonas I, et al. The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience. J Nucl Med. 2012;53(2):241–248.
   PubMed Web of Science ®Google Scholar
• Pedrizzetti G, Sengupta S, Caracciolo G, et al. Three-dimensional principal strain analysis for characterizing subclinical changes in left ventricular function. J Am Soc Echocardiogr. 2014;27(10):1041–1050.e1.
   PubMed Web of Science ®Google Scholar
• Voigt JU, Pedrizzetti G, Lysyansky P, et al. Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/industry task force to standardize deformation imaging. Eur Heart J Cardiovasc Imaging. 2015;16(1):1–11.
   PubMed Web of Science ®Google Scholar
• Tavakoli V, Sahba N. Assessment of age-related changes in left ventricular twist by 3-dimensional speckle-tracking echocardiography. J Ultrasound Med. 2013;32(8):1435–1441.
   PubMed Web of Science ®Google Scholar
• Wang Q, Gao Y, Tan K, et al. Subclinical impairment of left ventricular function in diabetic patients with or without obesity: a study based on three-dimensional speckle tracking echocardiography. Herz. 2015;40(S3):260–268.
   PubMed Web of Science ®Google Scholar
• Joyce E, Ninaber MK, Katsanos S, et al. Subclinical left ventricular dysfunction by echocardiographic speckle-tracking strain analysis relates to outcome in sarcoidosis. Eur J Heart Fail. 2015;17(1):51–62.
   PubMed Web of Science ®Google Scholar
• Barssoum K, Altibi AM, Rai D, et al. Speckle tracking echocardiography can predict subclinical myocardial involvement in patients with sarcoidosis: a meta-analysis. Echocardiography. 2020;37(12):2061–2070.
   PubMed Web of Science ®Google Scholar
• Russo C, Jaubert MP, Jin Z, et al. Intra- and interobserver reproducibility of left ventricular mechanical dyssynchrony assessment by real time three-dimensional echocardiography. Echocardiography. 2012;29(5):598–607.
   PubMed Web of Science ®Google Scholar
• Ma CY, Liu S, Zhang Q, et al. Calibration of the normal cutoff values of systolic dyssynchrony of the left ventricular synchronicity in normal subjects using real-time 3-dimensional echocardiography and the effects of age and heart rate. Cell Biochem Biophys. 2014;69(1):115–121.
   PubMed Web of Science ®Google Scholar
• Wang H, Song Y, Mu J, et al. Left ventricular systolic dyssynchrony in patients with kawasaki disease: a real-time three-dimensional echocardiography study. Int J Cardiovasc Imaging. 2020;36(10):1941–1951.
   PubMed Web of Science ®Google Scholar
• Migrino RQ, Harmann L, Woods T, et al. Intraventricular dyssynchrony in light chain amyloidosis: a new mechanism of systolic dysfunction assessed by 3-dimensional echocardiography. Cardiovasc Ultrasound. 2008;6:40.
   PubMed Web of Science ®Google Scholar
• Guerra VC, de Menezes Martins L, Oliveira RM, et al. Prevalence of left ventricular dyssynchrony in patients with congenital atrioventricular block and Long-Term pacing: a Three-Dimensional echocardiographic study. Echocardiography. 2015;32(9):1400–1406.
   PubMed Web of Science ®Google Scholar
• Soliman OI, Geleijnse ML, Theuns DA, et al. Usefulness of left ventricular systolic dyssynchrony by real-time three-dimensional echocardiography to predict long-term response to cardiac resynchronization therapy. Am J Cardiol. 2009;103(11):1586–1591.
   PubMed Web of Science ®Google Scholar
• Kapetanakis S, Bhan A, Murgatroyd F, et al. Real-time 3D echo in patient selection for cardiac resynchronization therapy. JACC Cardiovasc Imaging. 2011;4(1):16–26.
   PubMed Web of Science ®Google Scholar
• Karuzas A, Rumbinaite E, Verikas D, et al. Accuracy of three-dimensional systolic dyssynchrony and sphericity indexes for identifying early left ventricular remodeling after acute myocardial infarction. Anatol J Cardiol. 2019;22(1):13–20.
   PubMed Web of Science ®Google Scholar
• Huang XS, Gu CX, Yang JF, et al. A pilot study of systolic dyssynchrony index by real-time three-dimensional echocardiography predicting clinical outcomes to surgical ventricular reconstruction in patients with left ventricular aneurysm. Interact CardioVasc Thorac Surg. 2014;19(6):938–945.
   PubMed Web of Science ®Google Scholar
• Tsuji T, Tanaka H, Matsumoto K, et al. Capability of three-dimensional speckle tracking radial strain for identification of patients with cardiac sarcoidosis. Int J Cardiovasc Imaging. 2013;29(2):317–324.
   PubMed Web of Science ®Google Scholar
• Smiseth OA, Morris DA, Cardim N, Reviewers: This document was reviewed by members of the 2018–2020 EACVI Scientific Documents Committee, et al. Multimodality imaging in patients with heart failure and preserved ejection fraction: an expert consensus document of the european association of cardiovascular imaging. Eur Heart J Cardiovasc Imaging. 2022;23:e34–e61.
   PubMed Web of Science ®Google Scholar
• Kleijn SA, van Dijk J, de Cock CC, et al. Assessment of intraventricular mechanical dyssynchrony and prediction of response to cardiac resynchronization therapy: comparison between tissue doppler imaging and real-time three-dimensional echocardiography. J Am Soc Echocardiogr. 2009;22(9):1047–1054.
   PubMed Web of Science ®Google Scholar